SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 0.01 |
| Enterprise Value ($M) | 0.46 |
| Book Value ($M) | -0.45 |
| Book Value / Share | -0.02 |
| Price / Book | -0.02 |
| NCAV ($M) | -0.45 |
| NCAV / Share | -0.02 |
| Price / NCAV | -0.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.00 |
| Current Ratio | 0.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic Discountinued Operations | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Diluted Discontinued Operations | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GNMLF – Genomma Lab Internacional, S.A.B. de C.V. | GNMSF – Genmab A/S |
| GNTLF – Genetic Technologies Limited | GRTSQ – Gritstone bio, Inc. |
| GRTX – Galera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io